Clinical Trials Sponsored by Arthrex GmbH

Total 3356 results

DMG Dental Material Gesellschaft mbH

Recruiting

Clinical Efficacy of Crowns Fabricated Using LuxaCrown

LuxaCrown | Single Crown Restoration

India
DMG Dental Material Gesellschaft mbH

Withdrawn

12 Month Follow up in Vivo Icon Study on Fluorotic Teeth

Fluorosis | Oral Deseases
DMG Dental Material Gesellschaft mbH

Completed

Resin Infiltration and Resin Infiltration With Bleaching in Improving the Esthetics for Fluorosis Stains

Fluorosis | Dental Care | Caries Infiltration

India
AIO-Studien-gGmbH
Merck Sharp & Dohme LLC

Completed

Neoadjuvant Anti PD-1 Immunotherapy in Resectable Non-small Cell Lung Cancer (NEOMUN)

Non-small Cell Lung Cancer (NSCLC)

Germany
John Neoptolemos
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest; Deutsches... and other collaborators

Not yet recruiting

Adjuvant Trial in Patients With Resected PDAC Randomized to Allocation of Oxaliplatin- or Gemcitabine-based Chemotherapy by Standard Clinical Criteria or by a Transcriptomic Treatment Specific Stratification Signature

Pancreatic Ductal Adenocarcinoma

Sweden, Germany
Diakonie-Klinikum Schwäbisch Hall gGmbH
Aesculap AG

Completed

Short Stitch Monomax® (Short-Stitch)

Surgical Wound Infection | Dehiscence of Laparotomy Wound

Germany
Kliniken Ludwigsburg-Bietigheim gGmbH
Ovesco Endoscopy AG

Unknown

Endoscopic Full Thickness Resection in the Lower GI Tract With the "Full Thickness Resection Device" (WALL-RESECT)

Colorectal Adenomas | Submucosal Tumors

Germany
AIO-Studien-gGmbH
Merck Sharp & Dohme LLC

Not yet recruiting

Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome (HEAT)

Squamous Cell Carcinoma of the Larynx | Squamous Cell Carcinoma of the Oral Cavity | Squamous Cell Carcinoma of the Oropharynx | Squamous Cell Carcinoma of the Hypopharynx

Germany
AIO-Studien-gGmbH
Merck Sharp & Dohme LLC

Terminated

Study of Pembrolizumab Maintenance Following First-Line Platinum Based Chemotherapy in Patients With Metastatic Squamous - Non-Small Cell Lung Cancer (sNSCLC) (PRIMUS)

Metastatic Squamous Non-small Cell Lung Cancer

Germany
AIO-Studien-gGmbH
Novartis Pharmaceuticals; iOMEDICO AG

Completed

Study to Compare Vinorelbine In Combination With the mTOR Inhibitor Everolimus vs. Vinorelbin Monotherapy for Second-line Treatment in Advanced Breast Cancer (VicTORia)

Her2-negative Metastatic Breast Cancer | Her2-negative Locally Advanced Breast Cancer

Germany
Johannes Gutenberg University Mainz
AIO-Studien-gGmbH

Completed

Efficacy of Cetuximab in Combination With Irinotecan and 5- FU/FA in Treatment of Metastatic Gastric Cancer (GC-CIF-2005)

Adenocarcinoma of Stomach or Esophagogastric Junction

Germany
University of Applied Sciences for Health Professions...
LICA Life Care GmbH

Recruiting

Digital Solutions for Elderly Care by Informal Caregivers (DigiSECC)

Activities of Daily Living

Austria
Institut für Klinische Krebsforschung IKF GmbH...
Incyte Biosciences International Sàrl

Recruiting

Pemigatinib After Curative Local Therapy in Advanced iCCA With FGFR2 Fusion/Rearrangements

Intrahepatic Cholangiocarcinoma | FGFR2 Gene Mutation | FGFR2 Gene Translocation | FGFR2 Gene Rearrangement

Germany
KeifeRx, LLC
Worldwide Clinical Trials; Life Molecular Imaging GmbH; Sun Pharmaceuticals Industries...

Not yet recruiting

Evaluating the Efficacy and Safety of Nilotinib BE in Subjects With Early Alzheimer's Disease (NILEAD)

Alzheimer Disease
Queen Mary University of London
Hoffmann-La Roche; MedSIR; Westdeutsche Studiengruppe GmbH (WSG)

Active, not recruiting

Investigate the Contribution of Ipatasertib to Neoadjuvant Chemotherapy Plus Atezolizumab in TNBC (BARBICAN)

Triple Negative Breast Cancer

United Kingdom
Dana-Farber Cancer Institute
National Cancer Institute (NCI); Prometheus Laboratories; Miltenyi Biomedicine...

Active, not recruiting

Trial of Regulatory T-cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease

Chronic Graft Versus Host Disease | Chronic GVHD | Complications of Organ Transplant Stem Cells

United States
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

Post-Authorization Safety, Tolerability and Immunogenicity Evaluation of HyQvia in Pediatric PIDD Subjects

Primary Immunodeficiency Diseases (PID)

Denmark, United Kingdom, Czechia, France, Greece, Hungary, Slovakia, Sweden
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

Prospective and Retrospective, Non-interventional Study to Evaluate the Safety and Effectiveness of Obizur in Real-life Practice

Acquired Hemophilia A

United States, Italy, United Kingdom, Germany, Austria, Netherlands, France
GWT-TUD GmbH
Amsterdam UMC, location VUmc; BerGenBio ASA; Groupe Francophone des Myelodysplasies

Completed

Evaluating the Efficacy and Safety of Bemcentinib in Patients With Myelodysplastic Syndromes

Acute Myeloid Leukemia | High-risk Myelodysplastic Syndrome | Low-risk Myelodysplastic Syndrome

Germany, Netherlands, France
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Terminated

BAX 802 in CHA With Inhibitors (CHAWI)

Hemophilia A

Netherlands, Spain, Italy, Turkey, Bulgaria, United States, Canada, Germany, Norway, Poland, Russian Federation, South Africa
Deutsches Herzzentrum Muenchen
Bayerisches Staatsministerium für Wirtschaft; R & S GmbH und Co KG

Completed

Safety of a New Security Device in Patients With Implanted Cardiac Electronic Devices

Electromagnetic Interference

Germany
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

Post-Marketing Non-Interventional Safety Evaluation of Obizur in the Treatment of Bleeding Episodes for Patients With Acquired Hemophilia A

Acquired Hemophilia A

United States
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

Phase 3/4 Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Major Orthopedic Surgery

Hemophilia A

United States, Belgium, France, Norway, Netherlands, Austria, Hungary, Italy, Poland, Portugal, Romania, Russian Federation, Spain, Sweden
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

Real-world CANadian CUvitru Non-Interventional Study in Subjects Transitioning From Subcutaneous Immunoglobulin (CANCUN)

Primary Immunodeficiency Diseases (PID)

Canada
ResMed
Clinical Trial Center North Hamburg Germany; CRI-The Clinical Research Institute...

Terminated

European Home Mechanical Ventilation Registry (EHMVR)

Pulmonary Disease, Chronic Obstructive | Amyotrophic Lateral Sclerosis | Muscular Dystrophies | Duchenne Muscular Dystrophy | Myotonic Dystrophy | Spinal Cord Injury | Obesity Hypoventilation Syndrome | Kyphoscoliosis | Congenital Central Hypoventilation Syndrome | Myopathies

Germany
Hasselt University
Jessa Hospital; University of Zagreb; AIT Austrian Institute of Technology GmbH

Completed

Fast Assay for Pathogen Identification and Characterization - Prospective Study (FAPIC)

Sepsis

Belgium, Croatia
Institute for Clinical and Experimental Medicine
Charite University, Berlin, Germany; Miltenyi Biomedicine GmbH

Completed

Sequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantation

Kidney Transplantation
University Hospital Freiburg
Roche Pharma AG; Genzyme, a Sanofi Company; Astellas Pharma GmbH

Completed

Phase IV Study to Evaluate Calcineurin Inhibitor Reduced, Steroid Free Immunosuppression After Renal Transplantation (Harmony)

Disorder Related to Renal Transplantation

Germany
GE Healthcare
Quintiles, Inc.; i3 Statprobe; BIAFFIN GmbH & Co. KG (Biomolecular Interaction...

Completed

Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) Injection

Sarcoma | Renal Cell Carcinoma | Breast Cancer | Head and Neck Cancer | Lung Cancer | Solid Tumors | High Grade Gliomas

United States
Istanbul University
Dentsply Implants Manufacturing GmbH; Risus medikal, Thommen medical (Switzerland)...

Completed

The Use of Bone-, Tooth- and Mucosa- Supported Stereolithographic Guides for Dental Implant Placement (stereolitho)

Prosthesis | Dental Implants | Stereolithography

Turkey
Institut für Klinisch-Kardiovaskuläre Forschung...
AstraZeneca; Boehringer Ingelheim; Amgen; Sanofi-Aventis Deutschland GmbH; BMBf (Federal... and other collaborators

Unknown

Coronary Artery Disease and Renal Failure Registry (CAD-REF)

Coronary Artery Disease | Renal Failure

Germany
Bispebjerg Hospital
Akribes Biomedical GmbH; Vascular Research Unit and Department of Vascular...

Not yet recruiting

FORCEREPAIR - A Wound Exudate Investigation

Venous Leg Ulcer | Cytokines | Wound Healing | Non-healing Wound

Denmark
Institut für Klinische Krebsforschung IKF GmbH...
Hannover Medical School; AstraZeneca

Recruiting

Durvalumab and Tremelimumab in Combination With Either Y-90 SIRT or DEB-TACE for Intermediate Stage HCC

HCC | Hepatocellular Carcinoma Non-resectable

Germany
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD) (AHEAD)

Hemophilia A

Czechia, Switzerland, Denmark, Canada, Australia, Austria, France, United Kingdom, Italy, Sweden, Belgium, Brazil, China, Colombia, Greece, Hungary, Norway, Poland, Portugal, Russian Federation, Slovenia, Spain
Grupo Pulso
Hospital de Sant Pau; Nurogames GmbH; Fundació Tic Salut i Social

Completed

eMotiph: E-mental Health Solution for Patients With Schizophrenia

Schizophrenia

Spain
Takeda
Takeda Development Center Americas, Inc.; Baxalta Innovations GmbH, now part...

Completed

A Study of TAK-881 in Healthy Adults

Healthy Volunteers

United States
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

A Study to Assess the Tolerability, Safety, and Pharmacokinetics of Subcutaneous Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) With Ramp-up and No Ramp-up Dosing in Healthy Adult Participants

Healthy Volunteers

United States
Biotronik SE & Co. KG
IHF GmbH - Institut für Herzinfarktforschung; Qmed Consulting A/S

Completed

BIO monitorinG in Patients With Preserved Left ventricUlar Function AfteR Diagnosed Myocardial Infarction (BIO-GUARD-MI)

Myocardial Infarction | Myocardial Infarction Old | Myocardial Infarction, Acute

Spain, Denmark, United States, Germany, Latvia, Australia, Czechia, Belgium, France, Austria, Hungary, Netherlands, Poland, Slovakia
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

FEIBA Reconstitution Volume Reduction and Faster Infusion Study (FEIBA STAR)

Hemophilia A or B With Inhibitors

Croatia, North Macedonia, Ukraine
Chordate Medical
FGK Clinical Research GmbH; Vinnova (Swedish Governmental Agency for Innovation...

Completed

Study to Evaluate the Efficacy of Intranasal Kinetic Oscillation Stimulation in the Preventive Treatment of Chronic Migraine

Chronic Migraine

Finland, Germany
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

RIXUBIS PMS India (RIXUBIS PMS)

Hemophilia B

India
Prof. Dr. med. Wolfgang Bethge
Pfizer; medac GmbH; Neovii Biotech

Terminated

Multicenter Study of Peritransplantation Immunosuppression for Mismatched Hematopoietic Cell Transplantation After Reduced Intensity Conditioning

Patients Receiving Mismatched Allogeneic HCT

Germany
HiPP GmbH & Co. Vertrieb KG
Biofortis, Merieux NutriSciences; Waldkrankenhaus Protestant Hospital, Spandau and other collaborators

Completed

Safety of an Infant Formula With Hydrolysed Protein in Term Infants (HASI)

Growth

Germany
The University of Texas Health Science Center,...
Otto Bock Healthcare Products GmbH

Completed

Clinical Algorithm for Post-Stroke Gait Training With C-Brace

Hemiparesis Due to Stroke | Hemiplegia Due to Stroke

United States
Universitätsklinikum Hamburg-Eppendorf
Clinical Trial Center North (CTC North GmbH & Co. KG); Riemser

Active, not recruiting

Cyclophosphamide as Graft-versus-host Prophylaxis After Allogeneic Stem Cell Transplantation for Multiple Myeloma

Multiple Myeloma

Germany
Erbe Elektromedizin GmbH
NAMSA; Kansas City Veteran Affairs Medical Center; Erbe USA Incorporated

Terminated

Eradicating Barrett's Esophagus Using Radiofrequency Ablation or a Novel Hybrid Argon Plasma Coagulation Technique (BURN)

Barrett's Esophagus | High-grade Dysplasia in Barrett Esophagus | Low Grade Dysplasia in Barrett Esophagus

United States
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

Pregnancy Registry to Collect Long-Term Safety Data From Women Treated With HyQvia

Exposure During Pregnancy

Poland, Czechia, United States, Germany, Slovakia
Institut für Pneumologie Hagen Ambrock eV
Weinmann Geräte für Medizin GmbH + Co. KG

Completed

The Effects of Airtrapping on Sleep and Breathing in Non Invasive Ventilation (NIV) in COPD

COPD | Hypercapnic Respiratory Failure

Germany
Dr. Frank Behrens
SocraMetrics GmbH

Completed

TMP001 in Relapsing-remitting Multiple Sclerosis

Remitting-Relapsing Multiple Sclerosis

Germany
German CLL Study Group
Roche Pharma AG; Celgene; Mundipharma Research GmbH & Co KG

Completed

A Safety and Efficacy Trial of a Combination of Bendamustine, Rituximab and Lenalidomide in Patients With Chronic Lymphocytic Leukemia (CLL2P)

Chronic Lymphocytic Leukemia

Germany

Clinical Trials Sponsored by Arthrex GmbH

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritius

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations